Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.

MLA

Masellis, Mario, et al. “Dopamine D2 Receptor Gene Variants and Response to Rasagiline in Early Parkinson’s Disease: A Pharmacogenetic Study.” Brain: A Journal of Neurology, vol. 139, no. 7, July 2016, pp. 2050–62. EBSCOhost, https://doi.org/10.1093/brain/aww109.

APA

Masellis, M., Collinson, S., Freeman, N., Tampakeras, M., Levy, J., Tchelet, A., Eyal, E., Berkovich, E., Eliaz, R. E., Abler, V., Grossman, I., Fitzer-Attas, C., Tiwari, A., Hayden, M. R., Kennedy, J. L., Lang, A. E., Knight, J., & ADAGIO investigators. (2016). Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson’s disease: a pharmacogenetic study. Brain: A Journal of Neurology, 139(7), 2050–2062. https://doi.org/10.1093/brain/aww109

Chicago

Masellis, Mario, Shannon Collinson, Natalie Freeman, Maria Tampakeras, Joseph Levy, Amir Tchelet, Eli Eyal, et al. 2016. “Dopamine D2 Receptor Gene Variants and Response to Rasagiline in Early Parkinson’s Disease: A Pharmacogenetic Study.” Brain: A Journal of Neurology 139 (7): 2050–62. doi:10.1093/brain/aww109.